openPR Logo
Press release

Global Hyperemesis Gravidarum Treatment Market Scenario Highlighting Major Drivers & Trends, 2018-2028 // Duchesnay Inc., Ipca Laboratories Ltd., Medichem S.A., Novartis AG, Midatech Pharma US Inc., Genentech, Inc

03-13-2019 09:00 AM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Global Hyperemesis Gravidarum Treatment Market Scenario

The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price of drugs may hinder the growth of the hyperemesis gravidarum treatment market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2183

Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and anti-hitamines medications. Sometimes, in case of hospitalization intravenous fluid is given to the mother to restore the electrolyte balance, nutrients, and vitamins. Hyperemesis gravidarum treatment depends on the severity of symptoms in patients. Hyperemesis gravidarum needs to be diagnosed as early as possible to reduce the risk of morbidity of both mother and foetus.

As per a recent literature survey conducted by the State University of New York (SUNY) reveals that approximately 0.3 to 3% of pregnancy cases need hyperemesis gravidarum treatment.

Hyperemesis Gravidarum Treatment Market: Segmentation

Tentatively, the global hyperemesis gravidarum treatment market can be segmented on the basis of type of treatment, route of administration and distribution channel.

Based on Type of Treatment, the global hyperemesis gravidarum treatment market is segmented into:

Anti-histamine (Diclectin)
Prokinetic agent (Metoclopramide, Cisapride)
Vitamin-Mineral Supplement Tablets/ Dietary supplements (Pregvit)
Anti-reflux medications (Ranitidine, Lansoprazole)
Anti-emetic (Ondensetron)
Antacid
Other measures of treatment (Intravenous Fluid)
Based on Route of Administration (RoA), the global hyperemesis gravidarum treatment market is segmented into:

Peroral
Intravenous
To know more about the Hyperemesis Gravidarum Treatment Market Visit the link- https://www.factmr.com/report/2183/hyperemesis-gravidarum-treatment-market

Hyperemesis Gravidarum Treatment Market: Overview

The dietary supplements and anti-emetic medications are expected to generate significant revenue over the forecast in the global hyperemesis gravidarum treatment market, followed by prokinetic agents. People prefer OTC products rather than prescription drugs for hyperemesis gravidarum treatment, which is expected to drive the growth of the retail segment over the forecast period. Based on RoA, intravenous treatment is gaining popularity for hyperemesis gravidarum treatment because in this way the drugs directly get absorbed into the blood-stream, leaving no option to irritate the gastric mucosa. Some of the popular brands of hyperemesis gravidarum treatment include Diclectin (Duchesnay Inc.), Pregvit (Duchesnay Inc.), Zofran (Novartis AG), Zuplenz (Midatech Pharma US Inc.), Kytril (Genentech, Inc.), etc. 

Hyperemesis Gravidarum Treatment Market: Regional Outlook

Geographically, the global hyperemesis gravidarum treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa. North America is expected to be the dominant regional market for hyperemesis gravidarum treatment due to the growing awareness regarding use of prescription drugs. Europe is expected to contribute second large revenue share in the global hyperemesis gravidarum treatment market throughout the forecast period due increasing number of patients with need of hyperemesis gravidarum treatment. With increase in the expenditure for healthcare sector and growing awareness regarding hyperemesis gravidarum treatment among general population, the hyperemesis gravidarum treatment market is expected to grow at a significant CAGR in Asia Pacific. 

Hyperemesis Gravidarum Treatment: Key Players

The global Hyperemesis Gravidarum Treatment is highly fragmented with a large number of global players operating. Examples of some of the key players identified in the global hyperemesis gravidarum treatment market are Duchesnay Inc., Ipca Laboratories Ltd., Medichem S.A., Novartis AG, Midatech Pharma US Inc., and Genentech, Inc., among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. 

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2183

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://westminsternewsonline.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Hyperemesis Gravidarum Treatment Market Scenario Highlighting Major Drivers & Trends, 2018-2028 // Duchesnay Inc., Ipca Laboratories Ltd., Medichem S.A., Novartis AG, Midatech Pharma US Inc., Genentech, Inc here

News-ID: 1650710 • Views: 473

More Releases from Fact.MR

Research and Technological Innovations to Bolster Developments in Steel Tubes Ma …
The demand for steel tubes suffered amid the Covid-19 pandemic as the demand and supply slowed down. However, successful vaccine inoculation has meant that manufacturers are looking at the future with tempered optimism. Click Here to get a Sample (Including Full TOC, Table & Figures) https://www.factmr.com/connectus/sample?flag=S&rep_id=480 Recovery in the automobile industry will be key to future steel tube sales. Considering their value for their extreme strength and resistance for hazardous
Emulsion stabilizer for beverages market highly fragmented with 4% CAGR and free …
Global consumption of emulsion stabilizer for beverages is foreseen to surpass 210,000 MT in 2018, up from nearly 200,000 MT in 2017, as per Fact.MR valuation. The emulsion stabilizer for beverages market is poised to grow at a moderate CAGR of 4% during the forecast period 2018-2028. Buoyancy in the global food and beverage industry is likely to contribute to the steady growth of the emulsion stabilizers for beverages market.
Short Wave Infrared Market COVID 19 Impact & In-Depth Analysis till 2031 includi …
As short wave infrared (SWIR) technology provides extremely valuable quantitative information, short wave infrared camera industry have entered into new ventures like airborne platforms. A combination of short wave infrared camera and hyperspectral imager - Airborne Visible/Infrared Imaging Spectrometer (AVIRIS) - has been used on 4 aircraft platforms with the range of pixel sizes, as per the altitude at which they function. To get in-depth information view the report -
Fire Resistant Clothing Market: Favorable Macroeconomic Factors Induce Momentum …
Global flame retardant sales reached nearly 192 million square meter in 2018, with momentum likely to drive the market to a 6.2% y-o-y in 2019, according to Fact.MR’s latest analysis. Imposition of stringent regulatory rules and growing awareness about workers’ safety in high-risk industries worldwide continue to drive growth. Gains have also been driven by macroeconomic factors, notably stability in global oil prices and capital injection in infrastructure projects. The

All 5 Releases


More Releases for Hyperemesis

04-19-2019 | Health & Medicine
Fact.MR
Global Hyperemesis Gravidarum Market Projections Analyzed To Inspect Growth Tren …
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price
Global Hyperemesis Gravidarum Treatment Market Projected to Augment at a Notable …
This research assessment managed by FactMR works to highlight the expected transformations that will occur in the “Hyperemesis Gravidarum Treatment Market” market in the coming years. FactMR has worked diligently to compile primary market facets through this report titled “Global Hyperemesis Gravidarum Treatment Market Scenario Highlighting Major Drivers & Trends, 2018-2028” which will soon be published for benefitting the readers. The availability of crucial statistics such as market revenue, market
Central Pontine Myelinolysis Market Treatment Methods Analysis 2019 with Key Pla …
The market drivers for Central Pontine Myelinolysis Market are increasing risk factors and cases of liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc. Global Central Pontine Myelinolysis Market - Key players Some of key players profiled in the report
Central Pontine Myelinolysis Market with Major Players Like Fujifilm Holdings Co …
Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms. These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures
11-26-2018 | Health & Medicine
Fact.MR
Growth Predictions on Global Hyperemesis Gravidarum Treatment Market Through 202 …
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and
10-30-2018 | Health & Medicine
Fact.MR
Hyperemesis Gravidarum Treatment Market Projected to Experience Major Revenue Bo …
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and